The previous section outlined the general process and basic compliance requirements for NMPA renewal registration, helping enterprises successfully complete applications under routine circumstances. However, in practice, many overseas medical device companies face not standardized renewal scenarios but complex special situations involving mandatory standard updates (e.g., GB 9706), dynamic product classification adjustments, conditional approval compliance, and changes in import agents. These scenarios often fall outside the scope of general procedures, and mishandling any single step may lead to rejection of the renewal application, certificate invalidation, or even product withdrawal from the market. Therefore, this section provides clear compliance solutions for six high-risk special scenarios.

Within China's medical device import compliance system, NMPA registration certificate renewal is a routine compliance task for overseas medical device manufacturers, yet it is also a core area where compliance errors and certificate invalidation most frequently occur. Compared to domestic enterprises, overseas manufacturers commonly face challenges such as delayed access to regulatory updates, differences between Chinese and foreign compliance systems, poor control over timing, inadequate awareness of standard updates, and unfamiliarity with the agent liaison process. Many overseas companies often miss the statutory six-month application window, confuse the order of change registration versus renewal, fail to promptly adapt to new standards like GB 9706, or mishandle classification adjustments. These issues prevent normal renewal, leading to certificate expiration and forcing a complete de novo registration process, consuming substantial time, resources, and compliance costs, and directly disrupting market access in China.

International Trade Administration of Taiwan, China has assigned import code 508 and export code 533 to PFHxS, its salts, and related compounds.

In order to help enterprises better understand the filing status of health food (dietary supplements) in China, CIRS has gathered statistics on health foods approved in 2026 (as of June 30) and analyzed them from multiple perspectives.

On June 29, 2026, MOFCOM added 20 Japanese entities involved in enhancing Japan's military capabilities to the Export Control List.

Taiwan's Civil Aviation Administration has proposed aligning its aviation dangerous goods rules with the 2025-2026 ICAO Technical Instructions.

This article summarizes the core points based on the Technical General Principles for the Data of Registration and Filing of NCI.

Global CosIng, a leading cosmetic ingredient regulatory data platform developed by CIRS Group, today announced the official launch of Global CosIng 2.0!

GACC Decree No. 280 was promulgated on October 14, 2025, and officially entered into force on June 1, 2026.

Recently, the Annexes of the ASEAN Cosmetic Directive (ACD) were updated to the substances listed in Annexes II, III, IV and VI.